| Sergio R Vaisman, MD | |
|
1591 Medical Dr, Pottstown, PA 19464-3224 | |
| (610) 326-8005 | |
| (610) 327-9629 |
| Full Name | Sergio R Vaisman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 1591 Medical Dr, Pottstown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063487783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD023984E (Pennsylvania) | Primary |
| 207R00000X | Internal Medicine | MD023984E (Pennsylvania) | Secondary |
| Entity Name | Berks Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649525569 PECOS PAC ID: 2860643582 Enrollment ID: O20130716000431 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase Ib expansion study for CUDC-101 in patients with advanced head and neck, gastric, breast and liver cancers.
Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.
The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
› Verified 4 days ago
| Entity Name | Gps Physician Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109452 PECOS PAC ID: 9739447400 Enrollment ID: O20180123000502 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase Ib expansion study for CUDC-101 in patients with advanced head and neck, gastric, breast and liver cancers.
Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.
The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sergio R Vaisman, MD 1591 Medical Dr, Pottstown, PA 19464-3224 Ph: (610) 326-8005 | Sergio R Vaisman, MD 1591 Medical Dr, Pottstown, PA 19464-3224 Ph: (610) 326-8005 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase Ib expansion study for CUDC-101 in patients with advanced head and neck, gastric, breast and liver cancers.
Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.
The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
› Verified 4 days ago
Usman Zulfiqar, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1600 E High St, Pottstown, PA 19464 Phone: 610-327-7000 | |
Dr. Katherine Sprague Patil, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1591 Medical Dr, Pottstown, PA 19464 Phone: 610-326-8005 Fax: 484-945-0572 | |
Nainesh M Patel, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1591 Medical Dr, Pottstown, PA 19464 Phone: 610-326-8005 Fax: 610-718-0788 | |
Dr. Peter E Blackstone, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 Glasgow St, Pottstown, PA 19464 Phone: 484-948-0770 Fax: 484-945-0648 | |
Dr. Scott Eric Drobnis, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 119 Shoemaker Rd, Pottstown, PA 19464 Phone: 610-427-4919 | |
Kalyani Narra, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1600 E High St, Pmmc Regional Cancer Center, Pottstown, PA 19464 Phone: 610-327-7000 |